Delaying approval of a critical drug: safety, efficacy, economics, compassion.
D000163:Acquired Immunodeficiency Syndrome; D016638:Critical Illness; D015507:Drugs, Investigational; D005062:European Union; D035082:Federal Government; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D007239:Infections; D008889:Military Personnel; D009369:Neoplasms; D010344:Patient Advocacy; D005791:Patient Care; D011057:Politics; D011640:Public Policy; D012926:Social Control, Formal; D014481:United States; D014486:United States Food and Drug Administration
Health Care and Public Health; Professional Patient Relationship